S

Stille AB
STO:STIL

Watchlist Manager
Stille AB
STO:STIL
Watchlist
Price: 203 SEK -1.93% Market Closed
Market Cap: 1.8B SEK
Have any thoughts about
Stille AB?
Write Note

Stille AB
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Stille AB
Net Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
S
Stille AB
STO:STIL
Net Income
kr73.3m
CAGR 3-Years
43%
CAGR 5-Years
19%
CAGR 10-Years
N/A
Elekta AB (publ)
STO:EKTA B
Net Income
kr1.7B
CAGR 3-Years
1%
CAGR 5-Years
1%
CAGR 10-Years
N/A
S
Surgical Science Sweden AB
STO:SUS
Net Income
kr142.8m
CAGR 3-Years
80%
CAGR 5-Years
87%
CAGR 10-Years
N/A
CellaVision AB
STO:CEVI
Net Income
kr188.7m
CAGR 3-Years
10%
CAGR 5-Years
8%
CAGR 10-Years
16%
Getinge AB
STO:GETI B
Net Income
kr3.7B
CAGR 3-Years
-8%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Arjo AB (publ)
STO:ARJO B
Net Income
kr884m
CAGR 3-Years
1%
CAGR 5-Years
12%
CAGR 10-Years
N/A
No Stocks Found

Stille AB
Glance View

Market Cap
1.8B SEK
Industry
Health Care

Stille AB engages in the development and sale of medical equipment. The company is headquartered in Torshaella, Sodermanlands. The product portfolio is divided into two business lines. The Surgery business area develops, produces and markets handcrafted, forged surgical instruments for all fields of open surgery, with an emphasis on cardiovascular surgery, and reconstructive and aesthetic plastic surgery. Its products include scissors, forceps, artery forceps, needle holders and clamps, among others. The Patient Positioning area develops and manufactures two main groups of procedure-specific specialized tables for cardiovascular surgery and gynecology, urology and urodynamic examinations. As of December 31, 2011, the Company had two wholly owned subsidiaries, Stille Surgical Inc. and Stille Incentive AB. As of December 30, 2011, the it's largest shareholder was Linc Invest AB (39.81%). On September 2, 2013, the Company sold its business unit, Sonesta, to ADDvise Lab Solutions publ AB.

STIL Intrinsic Value
286.89 SEK
Undervaluation 29%
Intrinsic Value
Price
S

See Also

What is Stille AB's Net Income?
Net Income
73.3m SEK

Based on the financial report for Sep 30, 2024, Stille AB's Net Income amounts to 73.3m SEK.

What is Stille AB's Net Income growth rate?
Net Income CAGR 5Y
19%

Over the last year, the Net Income growth was 102%. The average annual Net Income growth rates for Stille AB have been 43% over the past three years , 19% over the past five years .

Back to Top